查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1665279

血球容积比测试设备市场机会、成长动力、产业趋势分析与预测 2025 - 2034

Hematocrit Test Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球血球容积比测试设备市场价值 38 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 4.4%。对精确、高效诊断工具的需求不断增长，使得血球容积比测试设备成为医疗保健服务中的关键组成部分。

血球容积比测试设备市场 - IMG1

市场分为仪器、试剂和消耗品，其中仪器类别（包括血球比容测试分析仪和仪表）占据领先地位。 2024年，该部门创造了最高收入，达22亿美元。这些设备对于定期监测血球浓度是必不可少的，强调了它们在医疗和诊断环境中的必要性。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 38亿美元
预测值 57亿美元
复合年增长率 4.4％

此外，市场还根据测试类型进行分类，包括基于实验室的测试和即时诊断（POC）测试。实验室测试成为主导领域，2024 年的收入为 25 亿美元。实验室的血球容积比测试设备对于诊断贫血、红血球增多症和脱水等一系列疾病至关重要，使其成为医疗诊断中必不可少的工具。

美国仍然是重要的市场参与者，其血细胞比容测试设备在 2024 年的收入为 14 亿美元。 预计该领域在 2025 年至 2034 年期间的复合年增长率为 3.9%。这些设备的应用涵盖临床和家庭医疗保健环境，确保它们在患者监测和护理中发挥关键作用。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 血液疾病盛行率不断上升
      • 对即时诊断检测的需求不断增长
      • 血液学检测的技术进步
    • 产业陷阱与挑战
      • 先进的血球比容仪价格昂贵
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 未来市场趋势
  • 价值链分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第 5 章：市场估计与预测：按产品，2021 年至 2034 年

  • 主要趋势
  • 仪器
    • 血球容积比测试分析仪
    • 血球容积比测试仪
  • 试剂和耗材

第 6 章：市场估计与预测：按模式，2021 年至 2034 年

  • 主要趋势
  • 实验室检测
  • 即时诊断（POC）检测

第 7 章：市场估计与预测：按应用，2021 年至 2034 年

  • 主要趋势
  • 贫血
  • 先天性心臟病
  • 真性红血球增多症
  • 其他应用

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 诊断实验室
  • 门诊手术中心
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • MENARINI Group
  • Abbott
  • BIO-RAD
  • Boule
  • Danaher
  • Diatron
  • EKF Diagnostics
  • Roche
  • HORIBA Medical
  • Mindray
  • NIHON KOHDEN
  • Nova Biomedical
  • SENSA CORE
  • SIEMENS Healthineers
  • Sysmex
简介目录
Product Code: 12760

The Global Hematocrit Test Devices Market was valued at USD 3.8 billion in 2024 and is projected to expand at a CAGR of 4.4% from 2025 to 2034. This robust growth is driven by a rising prevalence of blood disorders, a growing aging population, and continuous advancements in point-of-care testing technologies. The increasing demand for precise and efficient diagnostic tools positions hematocrit test devices as a critical component in healthcare delivery.

Hematocrit Test Devices Market - IMG1

The market is segmented into instruments, reagents, and consumables, with the instruments category-comprising hematocrit test analyzers and meters-leading the charge. In 2024, this segment generated the highest revenue of USD 2.2 billion. These devices are indispensable for the regular monitoring of blood cell concentrations, underscoring their necessity in both medical and diagnostic settings.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.8 Billion
Forecast Value$5.7 Billion
CAGR4.4%

Additionally, the market is categorized by testing type, including laboratory-based testing and point-of-care (POC) testing. Laboratory-based testing emerged as the dominant segment, accounting for USD 2.5 billion in revenue in 2024. With a projected CAGR of 4.2% from 2025 to 2034, this segment continues to thrive due to its ability to deliver highly precise and reliable results. Laboratory-based hematocrit testing devices are crucial for diagnosing a range of conditions, such as anemia, polycythemia, and dehydration, making them an essential tool in healthcare diagnostics.

The U.S. remains a significant market player, with hematocrit test devices generating USD 1.4 billion in revenue in 2024. This segment is forecasted to grow at a CAGR of 3.9% between 2025 and 2034. The increasing prevalence of blood disorders, such as anemia, sickle cell disease, and polycythemia, within the U.S. population fuels the demand for reliable hematocrit testing equipment. The adoption of these devices spans clinical and home healthcare settings, ensuring their pivotal role in patient monitoring and care.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of blood disorders
      • 3.2.1.2 Growing demand for point-of-care testing
      • 3.2.1.3 Technological advancements in hematology testing
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced hematocrit devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Porter’s analysis
  • 3.7 PESTEL analysis
  • 3.8 Gap analysis
  • 3.9 Future market trends
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Instruments
    • 5.2.1 Hematocrit test analyzer
    • 5.2.2 Hematocrit test meter
  • 5.3 Reagents and consumables

Chapter 6 Market Estimates and Forecast, By Modality, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Laboratory-based testing
  • 6.3 Point-of-care (POC) testing

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Anemia
  • 7.3 Congenital heart diseases
  • 7.4 Polycythemia vera
  • 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Diagnostic laboratories
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 MENARINI Group
  • 10.2 Abbott
  • 10.3 BIO-RAD
  • 10.4 Boule
  • 10.5 Danaher
  • 10.6 Diatron
  • 10.7 EKF Diagnostics
  • 10.8 Roche
  • 10.9 HORIBA Medical
  • 10.10 Mindray
  • 10.11 NIHON KOHDEN
  • 10.12 Nova Biomedical
  • 10.13 SENSA CORE
  • 10.14 SIEMENS Healthineers
  • 10.15 Sysmex